A Chemical Is Never Just “On the List”
Why chemical inventory checking should be at the heart of product stewardship
A deceptively simple question sits behind almost every chemical product placed on the market:
Are we allowed to use this substance here?
It sounds like a database query. Enter a chemical name or CAS number, find a matching record and report whether the substance is “listed”.
But experienced product stewards know that the real answer is rarely a straightforward yes or no.
A substance may be listed but inactive. It may be permitted only for particular uses, volumes or users. Its approval may be approaching expiry. It may require notification before manufacture or import. The substance may be acceptable, while the formulated product containing it still requires a separate authorisation.
Conversely, absence from a list does not always mean that a substance is prohibited. It may mean that the substance is considered new, that additional information must be submitted, or that a particular exemption or notification route needs to be assessed.
The type of list matters as much as the entry itself. Presence on a national inventory or approval list is usually a positive signal. On a restriction or prohibited-substance list, the reverse is true: being listed means the substance is controlled or banned, and absence from it may be the more favourable position. The real question behind every search is therefore not simply whether a substance appears on a list, but what that appearance means: whether it is a positive outcome, a negative one, or a result that calls for further investigation.
Inventory checking is therefore not simply about finding chemicals in databases. It is about translating fragmented regulatory information into defensible commercial decisions.
There is no single global chemical inventory
Companies sometimes talk about checking “the chemical inventory” as though a universal register exists.
It does not.
Instead, product stewards must navigate a network of national inventories, regional registers, sector-specific approval lists, restricted-substance lists and use-specific authorisations. Each was created for a different legal purpose and asks a slightly different question.
The US Toxic Substances Control Act Inventory, for example, contains existing chemical substances manufactured, processed or imported for uses covered by TSCA. Yet even within that inventory, substances can be designated as active or inactive. A company intending to reintroduce an inactive substance into US commerce must notify the Environmental Protection Agency before doing so.
Canada operates both a Domestic Substances List and a Non-domestic Substances List. A substance on the Canadian DSL generally does not require a new-substance notification, unless it is subject to Significant New Activity requirements. A substance on the NDSL, however, is still considered new to Canada, although reduced notification requirements may apply.
Australia’s inventory goes further than providing chemical identities. Records may contain regulatory obligations or conditions affecting manufacture and import, and searching the inventory is only the first step in determining the appropriate introduction category.
The lesson is important: the meaning of “listed” changes according to the list being searched.
The ECHA plant protection list illustrates the problem
ECHA’s Annex of Approved Active Substances for Plant Protection Products is a good example of why a list entry must be interpreted in context.
Finding an active substance on an EU approval list does not, by itself, establish that a formulated plant protection product can be sold throughout Europe.
The active substance must meet EU approval requirements, but the plant protection product containing it must also be authorised in the relevant EU country before it can be placed on the market or used.
The EU Pesticides Database also distinguishes between approved and non-approved active substances, low-risk substances, candidates for substitution and basic substances. It contains information on emergency authorisations and maximum residue levels as well. The database itself warns that it is provided for information and that legally authoritative information is published in the Official Journal of the European Union.
Approval is not necessarily permanent either. Active-substance approvals are time-limited, can be extended while renewal assessments are completed, and may ultimately be renewed or not renewed.
A product steward therefore needs to ask more than:
Is the substance listed?
The better questions are:
What exactly has been approved, for which purpose, under what conditions, until when, and what additional authorisations are still required?
That shift in questioning is the difference between performing a search and making a regulatory assessment.
Substance identity is often the first hidden risk
Chemical inventory checking depends on knowing precisely what substance is being assessed.
That may sound obvious, but supply-chain data is rarely as clean as the inventory search box assumes.
Commercial names may describe mixtures rather than substances. Different salts, hydrates, isomers and molecular forms may have different regulatory identities. Polymers and substances of unknown or variable composition can be particularly difficult to match. Some inventory entries use confidential accession numbers or masked names rather than public CAS numbers.
A safety data sheet can be a useful starting point, but it should not automatically be treated as definitive evidence of inventory status. A broad chemical description, an incorrect CAS number or an identity that covers only one constituent of a reaction product can produce a technically successful search and a completely wrong conclusion.
Good inventory work therefore begins with an identity package, not merely a chemical name. Depending on the substance, that package may include:
- CAS and EC numbers;
- recognised chemical and trade names;
- molecular or structural information;
- composition ranges;
- impurities and stabilisers;
- polymer or UVCB descriptions;
- confirmation from the manufacturer; and
- the relationship between the purchased material and the regulatory substance being searched.
- identify where a substance appears across multiple jurisdictions;
- distinguish between a confirmed match and a result requiring further investigation;
- record the date, source and reasoning behind a regulatory conclusion;
- connect substance status to products, formulations and suppliers;
- highlight products affected by a change to a list entry; and
- schedule reassessment when approvals, exemptions or transitional periods approach expiry.
Product stewardship starts by establishing what the substance actually is.
Presence on an inventory is not approval for every use
Another common mistake is to confuse inventory status with complete marketability.
A general industrial chemicals inventory may confirm that a substance is regarded as existing in a jurisdiction. It does not necessarily resolve obligations under legislation governing pesticides, biocides, cosmetics, pharmaceuticals, food contact materials, workplace exposure, transport, environmental emissions or consumer products.
A substance may therefore pass an industrial inventory check and still be unsuitable for the intended product or application.
This is why the product steward must connect three pieces of information: the substance, the intended use and the market.
Leave out any one of them and the answer may be misleading.
For example, the regulatory position of a substance used as an industrial processing aid may be quite different from the position of the same substance marketed as an active ingredient, incorporated into a consumer article or intended to come into contact withfood.
Inventory checking should never be detached from the product’s function and commercial claims.
Inventory checking belongs throughout the product lifecycle
In many organisations, inventory searches are performed late in product development, often when a customer requests confirmation or a shipment is already approaching a border.
By that stage, the business may already have invested in formulation, testing, packaging, manufacturing and marketing.
A better product stewardship model uses inventory intelligence much earlier.
During raw-material approval
Before a new raw material is accepted, its constituents should be checked against the inventories and relevant sector lists for current and foreseeable markets.
This helps prevent the business from becoming commercially dependent on a substance that cannot be introduced into an important jurisdiction without additional work.
During product development
Formulators should have visibility of regulatory coverage while selecting ingredients, rather than asking product stewardship to validate a finished formula after the technical work is complete.
The most effective restriction is the one designed out before launch.
Before entering a new market
A product sold successfully in one country should not be assumed to be portable to another. Every constituent must be considered within the legal framework and intended use of the destination market.
During supplier or manufacturing changes
A change in supplier, grade, manufacturing route, impurity profile or stabiliser can alter the substance identity being placed on the market. “Chemically equivalent” from a purchasing perspective does not always mean “regulatorily identical”.
Inventory status should therefore form part of formal change control.
During ongoing portfolio management
Regulatory lists do not stand still. Canada’s Domestic Substances List, for example, is amended on average 12 times each year to add, update or remove substances.
A conclusion reached during product launch can become outdated while the product remains on the market.
The product steward’s seven-step method
A defensible inventory assessment can be built around seven questions.
1. What is the exact substance?
Confirm the regulatory identity, not just the commercial description supplied by procurement.
2. Where will it be manufactured, imported and sold?
The relevant jurisdiction may depend on who imports the substance, where manufacturing occurs and how the supply chain is structured.
3. What is the intended use?
Determine whether the substance falls within industrial chemicals legislation or a more specific regulatory regime.
4. Which lists must be checked?
This may include general chemical inventories, active-substance approvals, restrictions, authorisation lists, significant-new-use provisions and sector-specific positive or negative lists.
5. What does the entry actually say?
Review status, scope, conditions, flags, quantities, expiry dates and notification obligations. Do not stop when the search returns a match.
6. What is the authoritative evidence?
Record the source, version or search date, substance identifiers, reasoning and any assumptions. Where a public database is informational, identify the underlying legal instrument or competent-authority decision.
7. What could change the conclusion?
Set triggers for reassessment, including supplier changes, formulation changes, entry into new markets and regulatory-list updates.
The output should not simply be a spreadsheet cell containing “Yes”.
It should be a short, traceable regulatory position explaining what the company may do, what conditions apply and what actions remain outstanding.
Move from isolated searches to regulatory coverage
Inventory checking is often managed through spreadsheets, supplier declarations, email chains and searches performed by different people at different times.
That approach may work for a handful of substances. It becomes fragile when a company has hundreds of products, thousands of constituents and multiple markets.
The more mature approach is to create a regulatory coverage record for every substance.
This record should connect a controlled substance identity to its status in each market, the applicable conditions, the supporting evidence, the products that contain it and the business activities that depend upon it.
That changes inventory information from a collection of search results into something operational.
A proposed formulation can be screened before development continues. A supplier change can identify affected markets automatically. A regulatory update can be linked to products, customers and revenue. A product steward can prioritise action according to business impact rather than manually searching for every possible consequence.
From manual searching to managed intelligence
The difficulty is not that chemical lists are unavailable. The difficulty is searching the right lists consistently, interpreting the results correctly and keeping those conclusions current across a large product portfolio.
For a small number of substances, this can be managed through individual database searches and carefully maintained spreadsheets. As the number of substances, suppliers and markets increases, however, the process becomes difficult to control.
This is where regulatory information systems can help. A capable system should be able to search a substance across multiple global inventories and regulatory lists, connect the results to a controlled chemical identity, and retain the evidence behind the assessment.
The important benefit is not simply that a search can be performed more quickly. It is that inventory information can be managed as part of an ongoing product stewardship process.
For example, a well-designed system should be able to help a product steward:
Used in this way, technology provides structure and traceability. It reduces the risk that important conclusions remain buried in personal spreadsheets, email correspondence or the knowledge of a single specialist.
It does not, however, remove the need for expert interpretation.
A search platform cannot determine the intended use of a substance unless that information has been properly captured. It cannot resolve an uncertain identity without reliable supplier data. Nor should it automatically treat every apparent match as evidence of compliance.
The role of the system is to bring the relevant information together and make the assessment repeatable. The role of the product steward is still to understand what the result means.
This distinction matters. Automating searches without improving the quality of regulatory decisions merely allows an organisation to reach weak conclusions more quickly. The objective should instead be a combination of efficient information retrieval, controlled evidence and informed professional judgement.
Active Steward is being developed around these principles. If you would like to understand how a system of this kind could support your own inventory checking and product stewardship, we would be glad to tell you more.
Product stewardship is not about collecting lists
The value of the product steward is not measured by how many databases they can search.
It is measured by their ability to turn regulatory information into decisions that allow the business to act confidently.
That means recognising when a positive result is only the beginning of the assessment. It means understanding when an apparently minor identity difference changes the regulatory position. It means looking ahead to approval expiry, new market entry and supplier changes rather than reacting after a problem appears.
Chemical inventories and approval lists are often treated as regulatory reference material.
Used properly, they are much more than that.
They are an early-warning system, a product-development control, a market-access map and a source of strategic intelligence about the resilience of a company’s portfolio.
The question is not simply whether a chemical appears on a list.
The real question is whether the business understands what that listing allows it to do, and whether it will still be able to do it tomorrow.